Brook Biotechnologies, Inc.

Stony Brook, NY 11790

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $855K
First Award Date 09/30/95
Most Recent Award Date 02/01/01

Key Personnel

Last Name Name Awards Contact
Glass John D Glass 7

7 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/01 - 04/30/02

Reliable immunodiagnosis of B. Burgdorferi infection is crucial for the timely diagnosis of Lyme disease. Early treatment of Lyme disease is important to limit or prevent serious damage to the nervous and musculoskeletal system. Current serologic assays use cultured B. burgdorferi as their antigen source. Because OspA is the major protein expres...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/15/00 - 01/31/01

Reliable immunodiagnosis of B. Burgdorferi infection is crucial for the timely diagnosis of Lyme disease. Early treatment of Lyme disease is important to limit or prevent serious damage to the nervous and musculoskeletal system. Current serologic assays use cultured B. burgdorferi as their antigen source. Because OspA is the major protein expres...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/99 - 01/31/00

Reliable immunodiagnosis of B. Burgdorferi infection is crucial for the timely diagnosis of Lyme disease. Early treatment of Lyme disease is important to limit or prevent serious damage to the nervous and musculoskeletal system. Current serologic assays use cultured B. burgdorferi as their antigen source. Because OspA is the major protein expres...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/98 - 10/31/99

The long term objective of this project is to produce recombinant-based diagnostic assays that will improve the accuracy and reduce the cost of testing for Lyme Disease. Having demonstrated that recombinant chimeric proteins containing immunodominant Borrelia burgdorferi antigens can detect Borrelia-specifi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/98 - 12/31/98

DESCRIPTION (Adapted from the applicant's abstract): Immunization with either Borrelia burgdorferi outer surface protein (Osp) A or OspC induces protective immunity to subsequent challenge with the strain of B. burgdorferi from which the Osp's were derived. However, OspA and OspC are heterogeneous ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/97 - 07/31/98

The long term objective of this project is to produce recombinant-based diagnostic assays that will improve the accuracy and reduce the cost of testing for Lyme Disease. Having demonstrated that recombinant chimeric proteins containing immunodominant Borrelia burgdorferi antigens can detect Borrelia-specifi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/95 - 06/30/96

Current ELISA assays for Lyme disease have a poor positive predictive value. Because of this and pending the development of improved methodologies, the Center for Disease Control recently issued new guidelines that all positive and equivocal B. burgdorferi serologic tests should be confirmed by ...